Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7M18

HeLa-tubulin in complex with cryptophycin 1

Summary for 7M18
Entry DOI10.2210/pdb7m18/pdb
Related7LXB
EMDB information23569 23615
DescriptorTubulin beta-3 chain, Tubulin alpha-1B chain, Cryptophycin 1, ... (5 entities in total)
Functional Keywordsanti-tumor, microtubule, tubulin-rings, polymerization-inhibitor, cell cycle
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains16
Total formula weight818460.19
Authors
Eren, E. (deposition date: 2021-03-12, release date: 2021-09-08, Last modification date: 2024-05-29)
Primary citationEren, E.,Watts, N.R.,Sackett, D.L.,Wingfield, P.T.
Conformational changes in tubulin upon binding cryptophycin-52 reveal its mechanism of action.
J.Biol.Chem., 297:101138-101138, 2021
Cited by
PubMed Abstract: Cryptophycin-52 (Cp-52) is potentially the most potent anticancer drug known, with IC values in the low picomolar range, but its binding site on tubulin and mechanism of action are unknown. Here, we have determined the binding site of Cp-52, and its parent compound, cryptophycin-1, on HeLa tubulin, to a resolution of 3.3 Å and 3.4 Å, respectively, by cryo-EM and characterized this binding further by molecular dynamics simulations. The binding site was determined to be located at the tubulin interdimer interface and partially overlap that of maytansine, another cytotoxic tubulin inhibitor. Binding induces curvature both within and between tubulin dimers that is incompatible with the microtubule lattice. Conformational changes occur in both α-tubulin and β-tubulin, particularly in helices H8 and H10, with distinct differences between α and β monomers and between Cp-52-bound and cryptophycin-1-bound tubulin. From these results, we have determined: (i) the mechanism of action of inhibition of both microtubule polymerization and depolymerization, (ii) how the affinity of Cp-52 for tubulin may be enhanced, and (iii) where linkers for targeted delivery can be optimally attached to this molecule.
PubMed: 34461087
DOI: 10.1016/j.jbc.2021.101138
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.38 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon